The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020 by Gloy, Viktoria, Schmitt, Andreas M., Düblin, Pascal, Hirt, Julian, Axfors, Cathrin, Kuk, Hanna, Pereira, Tiago V., Locher, Clara, Caquelin, Laura, Walter‐Claudi, Martin, Lythgoe, Mark P., Herbrand, Amanda, Kasenda, Benjamin, Hemkens, Lars G.

Get full text